Lakefront Biotherapeutics (LKFT) Non-cash Items (2016 - 2017)

Lakefront Biotherapeutics (LKFT) has reported Non-cash Items for 3 consecutive years, with $59.8 billion the latest figure, recorded in Q3 2018.

• In Q3 2018, Non-cash Items rose 111.3% year-over-year to $59.8 billion; the TTM figure through Sep 2018 stood at $26.7 billion (up 1416.32% YoY), while the FY2017 annual figure was -$8.7 million, down 251.96% from the prior year.
• Non-cash Items grew to $59.8 billion in Q3 2018 per LKFT's latest filing, from -$61.3 billion in the prior quarter.
• Across five years, Non-cash Items topped out at $59.8 billion in Q3 2018 and bottomed at -$61.3 billion in Q2 2018.
• Historically, Non-cash Items has averaged $21.7 million across 3 years, with a median of -$8.3 million in 2017.
• Annual changes were most pronounced in 2017 — Non-cash Items slumped 758806.96% — and 2018, when it soared 111.3%.
• Lakefront Biotherapeutics' Non-cash Items stood at -$3.5 million in 2016, then sank by 150.01% to -$8.7 million in 2017, then jumped by 684421.02% to $59.8 billion in 2018.
• Business Quant data shows LKFT's Non-cash Items at $59.8 billion in Q3 2018, -$61.3 billion in Q2 2018, and -$8.7 million in Q4 2017.